Background The present study aimed to investigate the dose response relationship between the prescriptions of antimicrobial agents and infection/colonization with methicillin resistant Staphylococcus aureus (MRSA) taking additional factors like stay in a health care facility into account. Methods Multi-centre retrospective study on a cohort of patients that underwent microbiological diagnostics in Belgium during 2005. The bacteriological results retrieved from 17 voluntary participating clinical laboratories were coupled with the individual antimicrobial consumption patterns (July 2004-December 2005) and other variables as provided by pooled data of health insurance funds. Multivariate analysis was used to identify risk factors for MRSA colonization/infection. Results A total of 6844 patients of which 17.5% died in the year 2005, were included in a logistic regression model. More than 97% of MRSA was associated with infection (clinical samples), and only a minority with screening/colonization (1.59%). Factors (95% CI) significantly (p≤<0.01) associated with MRSA in the final multivariate model were: admission to a long term care settings (2.79–4.46); prescription of antibiotics via a hospital pharmacy (1.30–2.01); age 55+ years (3.32–5.63); age 15–54 years (1.23–2.16); and consumption of antimicrobial agent per DDD (defined daily dose) (1.25–1.40). Conclusions The data demonstrated a direct dose-response relationship between MRSA and consumption of antimicrobial agents at the individual patient level of 25–40% increased risk per every single day. In addition the study indicated an involvement of specific healthcare settings and age in MRSA status.
References
[1]
Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, et al. (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36: 53–59. doi: 10.1086/345476
[2]
Monnet DL (1998) Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control. Infect Control Hosp Epidemiol 19: 552–559. doi: 10.1086/647872
[3]
Tacconelli E, De AG, Cataldo MA, Pozzi E, Cauda R (2008) Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 61: 26–38. doi: 10.1093/jac/dkm416
[4]
Safdar N, Bradley EA (2008) The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med 121: 310–315. doi: 10.1016/j.amjmed.2007.07.034
[5]
David MZ, Daum RS (2010) Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 23: 616–687. doi: 10.1128/cmr.00081-09
[6]
Goossens H, Ferech M, Vander SR, Elseviers M (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365: 579–587. doi: 10.1016/s0140-6736(05)17907-0
[7]
Rahal K, Wang F, Schindler J, Rowe B, Cookson B, et al. (1997) Reports on surveillance of antimicrobial resistance in individual countries. Clin Infect Dis 24 Suppl 1S169–S175. doi: 10.1093/clinids/24.supplement_1.s169
[8]
Grundmann H, de Kraker M, Davey P (2011) Clinical impact of antimicrobial resistance: design matters. Lancet Infect Dis 11: 344–345. doi: 10.1016/s1473-3099(11)70107-4
[9]
Costelloe C, Lovering A, Montgomery A, Lewis D, McNulty C, et al. (2012) Effect of antibiotic prescribing in primary care on meticillin-resistant Staphylococcus aureus carriage in community-resident adults: a controlled observational study. Int J Antimicrob Agents 39: 135–141. doi: 10.1016/j.ijantimicag.2011.09.022
[10]
Kuster SP, Ruef C, Ledergerber B, Hintermann A, Deplazes C, et al. (2008) Quantitative antibiotic use in hospitals: comparison of measurements, literature review, and recommendations for a standard of reporting. Infection 36: 549–559. doi: 10.1007/s15010-008-7462-z
[11]
Jans B, Schoevaerdts D, Huang TD, Berhin C, Latour K, et al. (2013) Epidemiology of multidrug-resistant microorganisms among nursing home residents in Belgium. PLoS One 8: e64908. doi: 10.1371/journal.pone.0064908
[12]
Vandendriessche S, Hallin M, Catry B, Jans B, Deplano A, et al. (2012) Previous healthcare exposure is the main antecedent for methicillin-resistant Staphylococcus aureus carriage on hospital admission in Belgium. Eur J Clin Microbiol Infect Dis 31: 2283–2292. doi: 10.1007/s10096-012-1567-0
[13]
Talon D, Woronoff-Lemsi MC, Limat S, Bertrand X, Chatillon M, et al. (2002) The impact of resistance to methicillin in Staphylococcus aureus bacteremia on mortality. Eur J Intern Med 13: 31–36. doi: 10.1016/s0953-6205(01)00189-3
[14]
Wyllie DH, Crook DW, Peto TE (2006) Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997–2003: cohort study 4. BMJ 333: 281. doi: 10.1136/bmj.38834.421713.2f